scholarly article | Q13442814 |
P356 | DOI | 10.1002/JCB.20458 |
P698 | PubMed publication ID | 15861394 |
P2093 | author name string | Emily Smith | |
Ian Paterson | |||
Max Robinson | |||
Maria Davies | |||
Stephen Prime | |||
Suzy Huntley | |||
P433 | issue | 5 | |
P921 | main subject | keratinocyte | Q1473931 |
P304 | page(s) | 918-931 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
P1476 | title | Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways | |
P478 | volume | 95 |
Q35106947 | A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples |
Q39123818 | APRIL depletion induces cell cycle arrest and apoptosis through blocking TGF-β1/ERK signaling pathway in human colorectal cancer cells |
Q50941164 | Amniotic membrane stimulates cell migration by modulating transforming growth factor-β signalling. |
Q34076300 | Association between shear stress and platelet-derived transforming growth factor-β1 release and activation in animal models of aortic valve stenosis |
Q36670886 | Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics |
Q35694314 | Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition |
Q33840143 | Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription. |
Q64922761 | Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks. |
Q36007887 | Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency |
Q39108074 | CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma |
Q46245500 | Culturable Endophytic Bacteria of Ginger Rhizome and their Remarkable Multi-trait Plant Growth-Promoting Features |
Q38626767 | Cytoskeletal signaling in TGFβ-induced epithelial-mesenchymal transition |
Q27306182 | DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells |
Q35515427 | DeltaNp63α protein triggers epithelial-mesenchymal transition and confers stem cell properties in normal human keratinocytes |
Q38335478 | Desmoglein 3: a help or a hindrance in cancer progression? |
Q92732996 | Dioscin Inhibits the Invasion and Migration of Hepatocellular Carcinoma HepG2 Cells by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition |
Q28080874 | Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death |
Q34178127 | Downregulation of thrombomodulin, a novel target of Snail, induces tumorigenesis through epithelial-mesenchymal transition |
Q27023960 | Ductal barriers in mammary epithelium |
Q39350198 | E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model. |
Q39241053 | EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells |
Q38544771 | Enamel matrix proteins exhibit growth factor activity: A review of evidence at the cellular and molecular levels |
Q35522530 | Endocytic deficiency induced by ITSN-1s knockdown alters the Smad2/3-Erk1/2 signaling balance downstream of Alk5 |
Q39066016 | Epidermal growth factor promotes transforming growth factor-β1-induced epithelial-mesenchymal transition in HK-2 cells through a synergistic effect on Snail. |
Q42442275 | Epidermal-like architecture obtained from equine keratinocytes in three-dimensional cultures. |
Q38166350 | Epithelial-mesenchymal Transition and Cell Invasion |
Q44267680 | Epithelial-mesenchymal transition and tumor drug resistance |
Q36442911 | Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5. |
Q44898872 | Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease |
Q36303720 | Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract |
Q35925292 | Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition. |
Q38965383 | High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer |
Q35842588 | High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells |
Q92853946 | Human Skin Keratinocytes on Sustained TGF-β Stimulation Reveal Partial EMT Features and Weaken Growth Arrest Responses |
Q37054538 | IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-β1 to induce bronchial epithelial-mesenchymal transition (EMT). |
Q38754843 | Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach |
Q35878640 | Implications of TGFβ on Transcriptome and Cellular Biofunctions of Palatal Mesenchyme |
Q52587547 | Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing. |
Q39955774 | Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells |
Q98894867 | Inhibition of Rho kinase suppresses capsular contraction following lens injury in mice |
Q34171181 | Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway. |
Q28265314 | JDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cells |
Q37469496 | KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells |
Q39051588 | MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells |
Q39514016 | Microenvironment induced spheroid to sheeting transition of immortalized human keratinocytes (HaCaT) cultured in microbubbles formed in polydimethylsiloxane |
Q35626150 | Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β). |
Q37588549 | Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition |
Q41285768 | New insights into the functions of intersectin-1s |
Q37259888 | Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway |
Q29620040 | Non-Smad pathways in TGF-beta signaling |
Q38782106 | Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis |
Q35807221 | Novel naphthochalcone derivative accelerate dermal wound healing through induction of epithelial-mesenchymal transition of keratinocyte |
Q39010093 | Nucleolin promotes TGF-β signaling initiation via TGF-β receptor I in glioblastoma |
Q33693105 | PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma |
Q39030323 | Parathyroid hormone related-protein promotes epithelial-to-mesenchymal transition in prostate cancer |
Q37407395 | Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models |
Q30498249 | Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition |
Q61810971 | Phosphorylation status at Smad3 linker region modulates transforming growth factor-β-induced epithelial-mesenchymal transition and cancer progression |
Q38764247 | Plasticity underlies tumor progression: role of Nodal signaling |
Q92881763 | Protective Effects of [6]-Gingerol Against Chemical Carcinogens: Mechanistic Insights |
Q35156138 | Resveratrol targets transforming growth factor-β2 signaling to block UV-induced tumor progression |
Q89509862 | Role of TGF- in Skin Chronic Wounds: A Keratinocyte Perspective |
Q36677493 | Role of transforming growth factor-beta in cancer progression |
Q37581437 | SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression |
Q39042970 | Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells |
Q47382904 | Separation of cell survival, growth, migration, and mesenchymal transdifferentiation effects of fibroblast secretome on tumor cells of head and neck squamous cell carcinoma |
Q37105954 | Singular value decomposition-based regression identifies activation of endogenous signaling pathways in vivo |
Q37163557 | Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects |
Q39024052 | Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells |
Q50138285 | Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell-secreted platelet-derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation. |
Q41412520 | Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition |
Q28508328 | TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA |
Q29619820 | TGF-beta-induced epithelial to mesenchymal transition |
Q42399810 | TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. |
Q46183468 | TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1 |
Q92723914 | TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis |
Q27310034 | TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis |
Q41332318 | TGFβ signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults |
Q39448837 | TGFβ upregulates PAR-1 expression and signalling responses in A549 lung adenocarcinoma cells |
Q39155151 | Targeting TGF-β Signaling for Therapeutic Gain |
Q47098255 | Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways |
Q48590220 | The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis. |
Q38946786 | The Downregulation of MicroRNA-146a Modulates TGF-β Signaling Pathways Activity in Glioblastoma |
Q36985643 | The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis |
Q37590740 | The ERK-ZEB1 pathway mediates epithelial-mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids. |
Q37485598 | The First Scube3 Mutant Mouse Line with Pleiotropic Phenotypic Alterations. |
Q47133908 | The Regulatory Effects of Transforming Growth Factor-β on Nerve Regeneration |
Q40867284 | The Roles of Mitogen-Activated Protein Kinase Pathways in TGF-β-Induced Epithelial-Mesenchymal Transition |
Q37261631 | The TGF-beta paradox in human cancer: an update |
Q39076794 | The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance. |
Q35718294 | The awakening of an advanced malignant cancer: an insult to the mitochondrial genome |
Q39438559 | The effect of JDP2 and ATF2 on the epithelial-mesenchymal transition of human pancreatic cancer cell lines |
Q37040558 | The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells |
Q54480779 | The prognostic role of TGF-β signaling pathway in breast cancer patients. |
Q33607396 | The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma. |
Q37633528 | Transforming growth factor-beta: a target for cancer therapy |
Q34789300 | Transforming growth factor-β and the hallmarks of cancer |
Q39380641 | Transforming growth factor-β enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes |
Q39447639 | Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma |
Q42461336 | Tumour-suppression function of KLF12 through regulation of anoikis. |
Q37934980 | Update on the chemopreventive effects of ginger and its phytochemicals |
Q58292739 | YAP drives cutaneous squamous cell carcinoma formation and progression |
Q34375528 | microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions |
Search more.